PAPER Martynova OO, Zakharov VV
SEARCH RESULTS
331710 RESULTS
PAPER Emelin AY, Odinak MM, Lobzin VY, Kolmakova KA
[Comparative characteristics of neuropsychological and neurometabolic changes in patients with Alzheimer's disease and vascular cognitive impairment].
Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(4. Vyp. 2):17-24. PubMed: 38696147PAPER Veverová K, Laczó J, Katonová A, Horáková H, Matušková V, Angelucci F, Laczó M, Nedelská Z, Hort J, Wang HL, Zhang J, Shi L, Fei Fang E, Vyhnálek M
Alterations of human CSF and serum-based mitophagy biomarkers in the continuum of Alzheimer disease.
Autophagy. 2024 May 2;:1-11. PubMed: 38695174PAPER Gülseren G, Demirsoy Z, Şeker M, Büyükünal OM
Exploring Bimetallic Nanoparticles in Alzheimer's Therapy: A Novel Bio-Assisted Synthesis with Multitarget Potential.
Mol Pharm. 2024 May 2; PubMed: 38698500PAPER Dietz CD, Albonico A, Tree JJ, Barton JJ
Visual imagery deficits in posterior cortical atrophy.
Cogn Neuropsychol. 2024 May 2;:1-16. PubMed: 38698499PAPER Shindo T, Eguchi K, Monma Y, Kanai H, Yasuda S, Shimokawa H
Optimal treatment conditions for low-intensity pulsed ultrasound therapy for Alzheimer's disease: applications from mice to humans.
J Med Ultrason (2001). 2024 May 2; PubMed: 38698287PAPER Kim HH, Kwon MJ, Jo S, Park JE, Kim JW, Kim JH, Kim SE, Kim KW, Han JW
Exploration of neuroanatomical characteristics to differentiate prodromal Alzheimer's disease from cognitively unimpaired amyloid-positive individuals.
Sci Rep. 2024 May 2;14(1):10083. PubMed: 38698190PAPER Durrant CS
Is amyloid-β a friend or foe?
Nat Rev Mol Cell Biol. 2024 May 2; PubMed: 38698078PAPER Tsitkov S, Valentine K, Kozareva V, Donde A, Frank A, Lei S, Answer ALS Consortium, E Van Eyk J, Finkbeiner S, Rothstein JD, Thompson LM, Sareen D, Svendsen CN, Fraenkel E
Disease related changes in ATAC-seq of iPSC-derived motor neuron lines from ALS patients and controls.
Nat Commun. 2024 May 2;15(1):3606. PubMed: 38697975PAPER Gouveia Roque C, Phatnani H, Hengst U
The broken Alzheimer's disease genome.
Cell Genom. 2024 Apr 23;:100555. PubMed: 38697121PAPER Ruiz-González C, Román P, Rueda-Ruzafa L, Cardona D, Requena M, Alarcón R
Environmental pesticide exposure and Alzheimer's disease in southern Spain: A cross-sectional study.
Psychiatry Res. 2024 Apr 27;337:115932. PubMed: 38696970PAPER Gainey M, Niles A, Imeh-Nathaniel S, Goodwin RL, Roley LT, Win O, Nathaniel TI, Imeh-Nathaniel A
Comorbidities in patients with vascular dementia and Alzheimer's disease with Neuropsychiatric symptoms.
Geriatr Nurs. 2024 May 1;57:217-223. PubMed: 38696879PAPER Ravichandran S, Snyder PJ, Alber J, Kenny MR, Rothstein A, Brown K, Murchison CF, Clay OJ, Roberson ED, Arthur E
Quantifying Putative Retinal Gliosis in Preclinical Alzheimer's Disease.
Invest Ophthalmol Vis Sci. 2024 May 1;65(5):5. PubMed: 38696189PAPER Nazir S, Iqbal RA
Recent Progress in the Application of Tau Protein Biosensors for Diagnosis of Neurodegenerative Diseases.
Appl Biochem Biotechnol. 2024 May 2; PubMed: 38696096PAPER Smith DM, Aggarwal G, Niehoff ML, Jones SA, Banerjee S, Farr SA, Nguyen AD
Biochemical, Biomarker, and Behavioral Characterization of the GrnR493X Mouse Model of Frontotemporal Dementia.
Mol Neurobiol. 2024 May 2; PubMed: 38696065Current Filters
No filters selected